A case report of recurrent endometriosis following Tibolone hormone replacement therapy.
Sundar
S S
SS
Department of Gynaecological Oncology, Gloucestershire Hospitals NHS Trust, UK. sudha.sundar@glos.nhs.uk
Gornall
R J
RJ
Kerr-Wilson
R
R
Swingler
G R
GR
Kinder
R B
RB
McCarthy
K
K
D004715:Endometriosis / Q000139:chemically induced*; D020847:Estrogen Receptor Modulators / Q000009:adverse effects*; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009652:Norpregnenes / Q000009:adverse effects*; D010532:Peritoneal Diseases / Q000139:chemically induced*; D012008:Recurrence
D020847:Estrogen Receptor Modulators; D009652:Norpregnenes; C027385:tibolone